Northwest Compounding Recalls Methocarbamol Liquid Due to Sterility Risks
Hiers Enterprises recalls Methocarbamol liquid 100mg/ml from Oregon due to lack of sterility assurance. Check lot numbers and expiration dates.
Stop using this now
Lack of sterility assurance.
Contact the company
What happened, in plain English
Hiers Enterprises, LLC dba Northwest Compounding Pharmacy is recalling Methocarbamol liquid 100mg/ml in glass vials because the products lack sterility assurance. The recall affects specific lots distributed exclusively in Oregon to medical facilities, physician offices, and consumers. Because sterility cannot be guaranteed, there is a risk of infection for patients using these compounded medications. Read more at govinfonow.com/recall/39258-northwest-compounding-recalls-methocarbamol-liquid-due-to-sterility-risks.
Source Summary by GovInfoNow · govinfonow.com/recall/39258-northwest-compounding-recalls-methocarbamol-liquid-due-to-sterility-risks · Updated October 11, 2026 · FDA enforcement record: FDA #D-0400-2019
Cite this page
“Northwest Compounding Recalls Methocarbamol Liquid Due to Sterility Risks.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/39258-northwest-compounding-recalls-methocarbamol-liquid-due-to-sterility-risks. Based on FDA recall #D-0400-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0400-2019%22&limit=1).
Why it’s dangerous
The primary hazard is a lack of sterility assurance, meaning the medication may contain harmful microorganisms. Using non-sterile injectable or liquid medications can lead to serious infections or other adverse health events in patients.
Who’s affected
Patients and medical facilities in Oregon who received this specific compounded Methocarbamol liquid between the production dates implied by the lot numbers and before the expiration dates. Consumers who purchased directly from the pharmacy are also affected.
How to tell if you have this one
Look for Methocarbamol liquid 100mg/ml in glass vials distributed in Oregon. Check for lot numbers starting with '10082018@34' (expiration 1/6/19) or '10312018@27' (expiration 1/29/19). The product was sold to 3 medical facilities, 1 physician's office, and 80 consumers.
- Brand
Northwest Compounding Pharmacy- Category
Drug
All 17 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Product was distributed exclusively in the state of Oregon to 3 Medical facilities, 1 Physician's office and 80 consumers/patients. These are compounded products - labels vary for each compound - specific to each patient. Firm did not provide labeling.
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0392-2019 | Cyclosporin liquid 2%, Rx, plastic dropper bottle, dry eye; 08172018@7 exp 2/13/19, 09202018@16 exp 3/2/19, 10172018@32 exp 3/2/19. | 830 ml |
| D-0393-2019 | Epinephrine liquid 1:1000, RX, glass vial; 10102018@13 exp 1/8/19, 10222018@33 exp 1/20/19, | 50 ml |
| D-0394-2019 | Glutathione liquid, 100mg/ml; 10292018@17 | 60 ml |
| D-0395-2019 | HCG liquid, 1000u/ml, RX, glass vial, various; 10162018@22 | 30 ml |
| D-0396-2019 | Hydroxyprogesterone liquid, 250mg/ml, RX, glass vial; 10252018@24 | 20 ml |
| D-0397-2019 | Lidocaine gel 2%, RX, plastic dropper; 10222018@15 | 125 ml |
| D-0398-2019 | Lidocaine/Epinepherine liquid 1%/ 1:1000, RX, glass vial These include injectable medications, sterile solutions, eye drops, and eye ointments; 08072018@30 | 50 ml |
| D-0399-2019 | MIC B vitamin liquid 25/50/50/1/1/1mg/ml RX glass vial; 1) 10192018@8 exp 2/28/19, MIC Ba w/ aminos 2) 10292018@15 exp 1/31/19, MIC B | 310 ml |
| D-0400-2019 | Methocarbamol liquid 100mg/ml, RX, glass vial; 10082018@34 exp 1/6/19, 10312018@27 exp 1/29/19 | 300 ml |
| D-0401-2019 | Testosteron Cypionate liquid 200mg/ml, RX, glass vial; 10012018@54 exp 3/30/19 | 200 ml |
| D-0402-2019 | Vitamin B12 liquid 1000mcg/ml, RX, glass vial; 10162018@28 exp 1/14/19, 10182018@38 exp 1/16/19 | 150 ml |
| D-0403-2019 | Cyclosporin liquid 1%, Rx, plastic dropper bottle; 07192018@12 | N/A |
| D-0404-2019 | Cyclosporin liquid 0.5%, Rx, plastic dropper bottle; 07272018@2 | N/A |
| D-0405-2019 | Cyclosporin liquid 0.2%, Rx, plastic dropper bottle; 10042018@10 | N/A |
| D-0406-2019 | Cyclosporin liquid 0.05%, Rx, plastic dropper bottle; 10122018@30 11022018@18 | N/A |
| D-0407-2019 | Glutathione liquid, 200mg/ml, Rx; 10092018@5 | N/A |
| D-0408-2019 | Lidocaine gel 1%, RX, plastic dropper; 10222018@40 | N/A |
What to do — step by step
Stop using the medication
Do not use any Methocarbamol liquid matching the recalled lot numbers or expiration dates.
Contact your provider
Reach out to the medical facility, physician's office, or pharmacy where you obtained the product for further instructions.
Where it went and when
Where it was distributed
Distributed in Oregon.
FDA distribution: “Product was distributed exclusively in the state of Oregon to 3 Medical facilities, 1 Physician's office and 80 consumers/patients. These are compounded products - labels vary for each compound - specific to each patient. Firm did not…” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Oregon.
Recall timeline
FDA terminated this recall 4.2 years after the firm started it.
- Firm started the recall
- Published in FDA’s Enforcement Report
- FDA classified it Class II
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0400-2019 (January 2, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0400-2019 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.